vs
Astrana Health, Inc.（ASTH）与EPAM Systems（EPAM）财务数据对比。点击上方公司名可切换其他公司
EPAM Systems的季度营收约是Astrana Health, Inc.的1.5倍（$1.4B vs $950.5M），EPAM Systems净利率更高（7.8% vs 0.7%，领先7.1%），Astrana Health, Inc.同比增速更快（42.9% vs 12.8%），EPAM Systems自由现金流更多（$268.1M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 9.9%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
EPAM Systems是总部位于美国宾夕法尼亚州纽敦的企业，核心业务涵盖软件工程服务、数字平台研发、数字产品设计三大板块，同时是MACH联盟的创始成员，在全球数字化服务赛道拥有深厚的技术积累与行业认可度。
ASTH vs EPAM — 直观对比
营收规模更大
EPAM
是对方的1.5倍
$950.5M
营收增速更快
ASTH
高出30.1%
12.8%
净利率更高
EPAM
高出7.1%
0.7%
自由现金流更多
EPAM
多$274.1M
$-6.0M
两年增速更快
ASTH
近两年复合增速
9.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.4B |
| 净利润 | $6.6M | $109.4M |
| 毛利率 | — | 30.1% |
| 营业利润率 | 1.9% | 10.6% |
| 净利率 | 0.7% | 7.8% |
| 营收同比 | 42.9% | 12.8% |
| 净利润同比 | 184.4% | 5.9% |
| 每股收益（稀释后） | $0.12 | $1.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHEPAM
| Q4 25 | $950.5M | $1.4B | ||
| Q3 25 | $956.0M | $1.4B | ||
| Q2 25 | $654.8M | $1.4B | ||
| Q1 25 | $620.4M | $1.3B | ||
| Q4 24 | $665.2M | $1.2B | ||
| Q3 24 | $478.7M | $1.2B | ||
| Q2 24 | $486.3M | $1.1B | ||
| Q1 24 | $404.4M | $1.2B |
净利润ASTHEPAM
| Q4 25 | $6.6M | $109.4M | ||
| Q3 25 | $373.0K | $106.8M | ||
| Q2 25 | $9.4M | $88.0M | ||
| Q1 25 | $6.7M | $73.5M | ||
| Q4 24 | $-7.8M | $103.3M | ||
| Q3 24 | $16.1M | $136.3M | ||
| Q2 24 | $19.2M | $98.6M | ||
| Q1 24 | $14.8M | $116.2M |
毛利率ASTHEPAM
| Q4 25 | — | 30.1% | ||
| Q3 25 | — | 29.5% | ||
| Q2 25 | — | 28.8% | ||
| Q1 25 | — | 26.9% | ||
| Q4 24 | — | 30.4% | ||
| Q3 24 | — | 34.6% | ||
| Q2 24 | — | 29.3% | ||
| Q1 24 | — | 28.4% |
营业利润率ASTHEPAM
| Q4 25 | 1.9% | 10.6% | ||
| Q3 25 | 2.0% | 10.4% | ||
| Q2 25 | 3.1% | 9.3% | ||
| Q1 25 | 3.3% | 7.6% | ||
| Q4 24 | 0.1% | 10.9% | ||
| Q3 24 | 5.9% | 15.2% | ||
| Q2 24 | 6.2% | 10.5% | ||
| Q1 24 | 7.5% | 9.5% |
净利率ASTHEPAM
| Q4 25 | 0.7% | 7.8% | ||
| Q3 25 | 0.0% | 7.7% | ||
| Q2 25 | 1.4% | 6.5% | ||
| Q1 25 | 1.1% | 5.6% | ||
| Q4 24 | -1.2% | 8.3% | ||
| Q3 24 | 3.4% | 11.7% | ||
| Q2 24 | 3.9% | 8.6% | ||
| Q1 24 | 3.7% | 10.0% |
每股收益（稀释后）ASTHEPAM
| Q4 25 | $0.12 | $1.97 | ||
| Q3 25 | $0.01 | $1.91 | ||
| Q2 25 | $0.19 | $1.56 | ||
| Q1 25 | $0.14 | $1.28 | ||
| Q4 24 | $-0.14 | $1.80 | ||
| Q3 24 | $0.33 | $2.37 | ||
| Q2 24 | $0.40 | $1.70 | ||
| Q1 24 | $0.31 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.3B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $3.7B |
| 总资产 | $2.2B | $4.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHEPAM
| Q4 25 | $429.5M | $1.3B | ||
| Q3 25 | $463.4M | $1.2B | ||
| Q2 25 | $342.1M | $1.0B | ||
| Q1 25 | $260.9M | $1.2B | ||
| Q4 24 | $290.8M | $1.3B | ||
| Q3 24 | $350.3M | $2.1B | ||
| Q2 24 | $327.7M | $1.8B | ||
| Q1 24 | $337.3M | $2.0B |
股东权益ASTHEPAM
| Q4 25 | $779.3M | $3.7B | ||
| Q3 25 | $775.5M | $3.7B | ||
| Q2 25 | $765.5M | $3.7B | ||
| Q1 25 | $745.4M | $3.6B | ||
| Q4 24 | $712.7M | $3.6B | ||
| Q3 24 | $704.6M | $3.6B | ||
| Q2 24 | $678.9M | $3.4B | ||
| Q1 24 | $653.5M | $3.5B |
总资产ASTHEPAM
| Q4 25 | $2.2B | $4.9B | ||
| Q3 25 | $2.2B | $4.8B | ||
| Q2 25 | $1.4B | $4.7B | ||
| Q1 25 | $1.3B | $4.7B | ||
| Q4 24 | $1.4B | $4.8B | ||
| Q3 24 | $1.3B | $4.5B | ||
| Q2 24 | $1.3B | $4.2B | ||
| Q1 24 | $1.2B | $4.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $282.9M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $268.1M |
| 自由现金流率自由现金流/营收 | -0.6% | 19.0% |
| 资本支出强度资本支出/营收 | 0.3% | 1.1% |
| 现金转化率经营现金流/净利润 | -0.44× | 2.59× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $612.7M |
8季度趋势，按日历期对齐
经营现金流ASTHEPAM
| Q4 25 | $-2.9M | $282.9M | ||
| Q3 25 | $10.0M | $294.7M | ||
| Q2 25 | $90.9M | $53.2M | ||
| Q1 25 | $16.6M | $24.2M | ||
| Q4 24 | $-10.9M | $130.3M | ||
| Q3 24 | $34.0M | $242.0M | ||
| Q2 24 | $23.2M | $57.0M | ||
| Q1 24 | $6.0M | $129.9M |
自由现金流ASTHEPAM
| Q4 25 | $-6.0M | $268.1M | ||
| Q3 25 | $7.4M | $286.4M | ||
| Q2 25 | $89.5M | $43.4M | ||
| Q1 25 | $13.6M | $14.8M | ||
| Q4 24 | $-13.5M | $114.5M | ||
| Q3 24 | $31.7M | $237.0M | ||
| Q2 24 | $20.4M | $52.3M | ||
| Q1 24 | $5.6M | $123.2M |
自由现金流率ASTHEPAM
| Q4 25 | -0.6% | 19.0% | ||
| Q3 25 | 0.8% | 20.5% | ||
| Q2 25 | 13.7% | 3.2% | ||
| Q1 25 | 2.2% | 1.1% | ||
| Q4 24 | -2.0% | 9.2% | ||
| Q3 24 | 6.6% | 20.3% | ||
| Q2 24 | 4.2% | 4.6% | ||
| Q1 24 | 1.4% | 10.6% |
资本支出强度ASTHEPAM
| Q4 25 | 0.3% | 1.1% | ||
| Q3 25 | 0.3% | 0.6% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.4% | 1.3% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 0.6% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ASTHEPAM
| Q4 25 | -0.44× | 2.59× | ||
| Q3 25 | 26.69× | 2.76× | ||
| Q2 25 | 9.65× | 0.60× | ||
| Q1 25 | 2.48× | 0.33× | ||
| Q4 24 | — | 1.26× | ||
| Q3 24 | 2.11× | 1.77× | ||
| Q2 24 | 1.21× | 0.58× | ||
| Q1 24 | 0.40× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
EPAM
暂无分部数据
